1. Home
  2. PSNL vs IPI Comparison

PSNL vs IPI Comparison

Compare PSNL & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • IPI
  • Stock Information
  • Founded
  • PSNL 2011
  • IPI 2000
  • Country
  • PSNL United States
  • IPI United States
  • Employees
  • PSNL N/A
  • IPI N/A
  • Industry
  • PSNL Medical Specialities
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • PSNL Health Care
  • IPI Industrials
  • Exchange
  • PSNL Nasdaq
  • IPI Nasdaq
  • Market Cap
  • PSNL 576.8M
  • IPI 518.6M
  • IPO Year
  • PSNL 2019
  • IPI 2008
  • Fundamental
  • Price
  • PSNL $6.59
  • IPI $36.71
  • Analyst Decision
  • PSNL Strong Buy
  • IPI Strong Sell
  • Analyst Count
  • PSNL 5
  • IPI 1
  • Target Price
  • PSNL $8.00
  • IPI $19.00
  • AVG Volume (30 Days)
  • PSNL 1.6M
  • IPI 166.7K
  • Earning Date
  • PSNL 08-06-2025
  • IPI 08-04-2025
  • Dividend Yield
  • PSNL N/A
  • IPI N/A
  • EPS Growth
  • PSNL N/A
  • IPI N/A
  • EPS
  • PSNL N/A
  • IPI N/A
  • Revenue
  • PSNL $85,694,000.00
  • IPI $217,865,000.00
  • Revenue This Year
  • PSNL $0.45
  • IPI $11.06
  • Revenue Next Year
  • PSNL $25.75
  • IPI N/A
  • P/E Ratio
  • PSNL N/A
  • IPI N/A
  • Revenue Growth
  • PSNL 15.57
  • IPI N/A
  • 52 Week Low
  • PSNL $1.14
  • IPI $20.75
  • 52 Week High
  • PSNL $7.20
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 69.33
  • IPI 53.96
  • Support Level
  • PSNL $6.27
  • IPI $34.20
  • Resistance Level
  • PSNL $7.03
  • IPI $35.93
  • Average True Range (ATR)
  • PSNL 0.43
  • IPI 1.28
  • MACD
  • PSNL 0.00
  • IPI -0.12
  • Stochastic Oscillator
  • PSNL 66.29
  • IPI 59.31

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: